REF
Click for more information
0.00% 0.3¢ reverse corp limited

Ann: Preliminary Final Report, page-4

  1. Patient
    2,443 Posts.
    lightbulb Created with Sketch. 213
    clock Created with Sketch.
    31/08/19
    07:32
    Post #: 40256860
    The Board is now focused on identifying the best option for the sale of the ASX-listed shell compromisingthe following assets:

    - $110,000 in cash
    - $140,000 due 1 July 2020 from the holdback on the online contact lenses business sale
    - $3,300,000 in franking / imputation credits

    Subs approx

    MVT/Sandon 19.98% 18.4m
    Richard Bell 19.8% 18.2m
    Phoenix $7.8% 7.3m

    Only 92m shares

    REF Price at posting: 1.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
WR1 Stock watchers charged up by Winsome Resources' latest lithium drilling results
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
watchlist Created with Sketch. Add REF (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.